Dr. Jeremy Orr brings more than 25 years of clinical medical practice, population health, and digital health leadership experience to the CEO role. Before joining Opala, Jeremy served as Chief Medical Officer of Boston-based clinical data analytics firm Humedica (now Optum Analytics), Chief Medical Officer of Los Angeles-based clinical decision support company Stanson Health (now part of Premier Inc.), and CEO of Israel-based clinical machine learning company Medial EarlySign. Jeremy holds an MD from the University at Buffalo and an MPH in epidemiology from Tulane University.
Shahryar Qadri is an entrepreneurial leader who brings more than 18 years of experience in healthcare information technology. Prior to Opala, Shahryar was the Chief Technology Officer at RxSavings Solutions, where he led the engineering organization to create technology that helps over 8 million members save money on their prescriptions. Shahryar also spent more than a decade at Cerner Corporation, where he held a variety of leadership roles in data warehousing, business intelligence and population health. Shahryar was the technology leader responsible for the creation of Cerner’s Third-Party Administrator (TPA) business and developed innovations in real-time claim adjudication, real-time eligibility check, on-site health clinics and wellness programs. Shahryar has a BS from Creighton University in Computer Science.
Dr. Meghan Quint is a multi-functional leader with a diverse background in corporate strategy, data and analytics, and innovation. She led several strategic partnerships with Silicon Valley startups to accelerate digital transformation and healthcare innovation at Premera Blue Cross and has held research and instructor positions at various universities with expertise in organizational effectiveness, leadership decision making, corporate culture, and change management. She is a master at translating and solving business needs through efficient and automated technical solutions, especially in the healthcare industry. She has a PhD and MA in Industrial/Organizational Psychology from Seattle Pacific University and a BA in Business Administration and BS in Psychology from the University of Washington (Seattle). She is a champion for women at work and is passionate about leveraging data and technology to improve the US healthcare system.
Jessica Owens has over 20 years of Talent Acquisition experience building high performance teams and products. Jessica launched her career in the IT consulting industry where she supported clients, such as IBM, Mayo Clinic, and Wells Fargo for 10 years. Next, she transitioned to internal roles growing Fortune 500 and startups alike, including Starbucks and Bungie. At Bungie, Jessica grew the studio from 128 to 600+ employees and launched two major products during her tenure. Most recently, she spent 5 years scaling Facebook’s Oculus AR/VR team both domestically and internationally with responsibilities across Recruiting, Research, Development and Product. As an advocate for diversity, Jessica is passionate about building a culture of equity and inclusion.
Sid Wang has over 30 years of experience designing and implementing technology solutions and services to address enterprise needs on a global scale. In 1997, Sid joined Starbucks with just over 1,000 stores and grew corporate IT infrastructure over the next 18 years ultimately in the role of Global IT Infrastructure Service Delivery Manager and Infrastructure Sourcing to support over 22,500 stores and $19 billion in revenue by 2015. Most recently, Sid developed deep expertise in healthcare data privacy and security at Premera Blue Cross, a health plan in the Pacific Northwest, where he spent 5 years managing operations and reporting of data and analytics infrastructure. Sid has a BS from Gonzaga University in Computer Science.
Kent Marquardt has over 30 years of healthcare experience with a track record of helping entrepreneurs create significant and successful enterprises. Kent joined Cardinal Partners as an advisor in 2017 and since October 2018 has served as a General Partner of the firm. Utilizing his over 30 years of healthcare and investment expertise, Kent’s investment focus at Cardinal is in AI and machine learning companies and technology-enabled services to drive next generation of member experience and engagement. Kent currently serves on the Board of Directors of Prealize, a Cardinal portfolio company and Brook. He is also a strategic advisor to VIM and Tuzag.
Prior to joining Cardinal Partners, Kent was EVP and CFO of Premera Blue Cross for 19 years, where he led Innovation and Strategic Investments. He drove early development and Premera investments in the several companies, including Landmark, Mobe, Prealize, and VIM.While at Premera, he led the development of the Blue CFO group and developed key relationships with a number of Blue plans, including Florida Blue, North Carolina, South Carolina, Highmark, IBC, Nebraska, Arizona, Tennessee, and Michigan.
Most recently, Kent has been CEO of Maverick Advisors, LLC, since July 2017. Maverick Advisors specializes in innovation and strategy with early stage companies and focuses on companies using advanced analytics and customer engagement to reduce healthcare inefficiencies. Kent has worked with a number of early stage companies to develop and refine their strategy and transition to a viable product offering. One example of this is his work with VIM to shift their focus to be an innovative referral management and curator of specialists, along with the connector of the last mile of healthcare services to the member, health plans, and providers.
Kent is also the managing partner of Balboa Winery and Stoney Vine Vineyard. Kent received his BBA degree in accounting from University of Wisconsin (Whitewater) and MBA from University of Wisconsin (Madison).
Thomas McKinley has over 35 years of venture capital investment experience with a successful track record of helping entrepreneurs create significant and successful enterprises. Tom joined Cardinal Partners as an advisor in 2008, and since January 2009 has served as General Partner. Utilizing his over 35 years of technology investment expertise, Tom’s investment focus at Cardinal is in healthcare information technology, technology-enabled services, AI, ML, and blockchain in healthcare. Most recently, Tom has been the founder, interim CEO and chairman of Prealize, a project in conjunction with Professors Arnold Milstein and Nigam Shah at Stanford University. Tom also has led Cardinal investments in lifeIMAGE, a cloud-based medical imaging sharing platform for hospitals, physicians, and patients. Tom led the firm’s investment in 2009 in virtual care company, Teladoc Health (NYSE: TDOC), a telehealth services provider of doctor consults to consumers with a current market value of $22 billion dollars. Tom currently serves on the Board of Directors of Cardinal portfolio companies, Prealize Health, lifeIMAGE, Teladoc Health, and Sapphire Digital, a web-based physician directory and decision support tools for patient engagement and steerage platform. At Project Connect, Tom was the founding CEO.
Tom has served on the boards of U.C. Berkeley’s Entrepreneurs Forum and the Western Association of Venture Capitalists (WAVC). He was an active member of the Health Management Academy (HMA), and an active supporter of the University of San Francisco’s Entrepreneurship Program. As an alumnus, Tom maintains close ties with Stanford’s Graduate School of Business, as well as Harvard University, where he serves as class secretary and started the Harvard College i3 Innovation Challenge, an undergraduate startup competition.
Tom received his AB degree in Economics from Harvard University, MS in Accounting from the Stern School of Business at New York University, and MBA from Stanford University Graduate School of Business.
Dr. Jeremy Orr brings more than 25 years of clinical medical practice, population health, and digital health leadership experience to the CEO role. Before joining Project Connect, Jeremy served as Chief Medical Officer of Boston-based clinical data analytics firm Humedica (now Optum Analytics), Chief Medical Officer of Los Angeles-based clinical decision support company Stanson Health (now part of Premier Inc.), and CEO of Israel-based clinical machine learning company Medial EarlySign. Jeremy holds an MD from University at Buffalo and an MPH in Epidemiology from Tulane University.
Dr. Julia Adler-Milstein is a Professor of Medicine and Director of the Center for Clinical Informatics and Improvement Research. She is a leading researcher in health IT policy with a specific focus on electronic health records and interoperability. She has examined policies and organizational strategies that enable effective use of electronic health records and promote interoperability. She is also an expert in EHR audit log data and its application to studying clinician behavior. Her research identifies obstacles to progress and ways to overcome them and is used by researchers, health systems, and policymakers.
Julia has published over 100 influential papers, has testified before the US Senate Health, Education, Labor and Pensions Committee, is a member of the National Academy of Medicine, has been named one of the top 10 influential women in health IT, and has won numerous awards, including the New Investigator Award from the American Medical Informatics Association and the Alice S. Hersh New Investigator Award from AcademyHealth. She has served on an array of influential committees and boards, including the NHS National Advisory Group on Health Information Technology, the Health Care Advisory Board for Politico, and the Interoperability Committee of the National Quality Forum. Her private sector experience includes advising numerous health IT companies and time as a consultant at Accenture.
Julia holds a PhD in Health Policy from Harvard and spent six years on the faculty at University of Michigan prior to joining the University of California San Francisco as a Professor in the Department of Medicine and the inaugural director of the Center for Clinical Informatics and Improvement Research.
Jim Messina is EVP and COO at Premera Blue Cross. He is responsible for effectively servicing the needs of Premera’s customers with oversight of all operational functions, from customer service to billing to claims processing. Messina also leads Sales and Marketing, where he is responsible for growth and earnings across all markets and business lines throughout Premera. Within the Sales and Marketing organization, he is accountable for Product and Brand Development, as well as external Marketing. Finally, he drives continuous improvement, throughout Premera, leveraging the LEAN methodology and ensures business activities are data-driven in order to achieve sustainable growth.
Messina joined Premera in January 2009 as VP and General Manager, leading sales efforts for national, labor and special accounts, and consulting services. His career spans over 30 years in the insurance industry, where he has held various strategic, business, and financial planning positions with a number of health plans.
Prior to joining Premera, Messina served as President and CEO of CareSite Pharmacies. He previously served as CEO and President of HealthMarket, a consumer-driven insurance company. Messina also served in senior level roles at CIGNA and UnitedHealth Group.
Messina received a BA in Accounting from the University of Arizona.
Molly Coye, MD
Executive in Residence at AVIA and Board Member at Amedisys, Ginger, and ConsejoSano
Douglas Fridsma, MD, PhD
Board Member at IHTSDO, past President and CEO at American Medical Informatics Association and past Chief Science Officer at U.S. Department of Health and Human Services
CEO at IVX Health, Board Member at ClarisHealth and XSOLIS, former President at Change Healthcare, and former SVP of Client Solutions at CVS Health
CEO at First Light Advisors, Board Member at Radiology Partners, and former COO at DaVita Medical Group
VP of Provider Strategy & Collaboration at Premera Blue Cross
Lee Sacks, MD
Past EVP and Chief Medical Officer at Advocate Health Care
Nigam Shah, MBBS, PhD
Professor of Medicine (Biomedical Informatics) at Stanford University, Associate CIO for Data Science at Stanford Health Care
Mark Smith, MD
Clinical Professor of Medicine at UCSF; Board Member at Teladoc Health, Phreesia, and Jazz Pharmaceuticals, former CEO of the California HealthCare Foundation
Co-founder and Managing Partner at Cardinal Partners, Board Director for Abide Therapeutics, aTyr Pharma, Ivenix, Vividion Therapeutics, and Alnylam Pharmaceuticals.
Chief Data & Analytics Officer at Premera Blue Cross